Published in Antimicrob Agents Chemother on June 01, 1986
Fluoroquinolone antimicrobial agents. Clin Microbiol Rev (1989) 6.45
Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol (2012) 1.69
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother (1994) 1.49
Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrob Agents Chemother (1994) 1.23
Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother (1987) 1.07
Antibiotic residues and drug resistance in human intestinal flora. Antimicrob Agents Chemother (1987) 0.98
Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice. Antimicrob Agents Chemother (1991) 0.90
Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group. Antimicrob Agents Chemother (1993) 0.89
Ofloxacin and penicillin G combination therapy in prevention of bacterial translocation and animal mortality after irradiation. Antimicrob Agents Chemother (1991) 0.85
Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother (1989) 0.85
Effect of quinolones on the human intestinal microflora. Drugs (1995) 0.80
Minimum antibiotic levels for selecting a resistance plasmid in a gnotobiotic animal model. Antimicrob Agents Chemother (1989) 0.80
Impact of the fluoroquinolones on gastrointestinal flora. Drugs (1993) 0.80
Selective decontamination in neutropenic patients. Epidemiol Infect (1992) 0.78
Rodent models to study the relationships between mammals and their bacterial inhabitants. Gut Microbes (2012) 0.78
In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids. Antimicrob Agents Chemother (1994) 0.78
Human flora-associated rodents--does the data support the assumptions? Microb Biotechnol (2008) 0.76
Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit. Drugs (1995) 0.75
Isolation of anaerobic bacteria from human gingiva and mouse cecum by means of a simplified glove box procedure. Appl Microbiol (1969) 14.62
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med (1984) 3.26
Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis (1985) 2.69
Antibacterial activity of norfloxacin. Antimicrob Agents Chemother (1983) 2.15
Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora. J Infect Dis (1983) 1.90
Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother (1982) 1.87
Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance. Infect Immun (1985) 1.74
[Practical modifications concerning the determination of antibiotics in clinical practice]. Rev Fr Etud Clin Biol (1957) 1.72
Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J Infect Dis (1981) 1.48
Antagonistic effect of extremely oxygen-sensitive clostridia from the microflora of conventional mice and of Escherichia coli against Shigella flexneri in the digestive tract of gnotobiotic mice. Infect Immun (1977) 1.36
Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers. J Infect Dis (1984) 1.21
Importance of host factors in human salmonellosis caused by multiresistant strains of Salmonella. J Infect Dis (1984) 1.19
Plasmid-mediated susceptibility to intestinal microbial antagonisms in Escherichia coli. Infect Immun (1985) 1.19
On the logarithmid transformation of intestinal bacterial counts. Am J Clin Nutr (1970) 1.12
Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. J Infect Dis (1983) 1.02
Effect of antibiotics on the human intestinal flora in mice. Antonie Van Leeuwenhoek (1983) 0.95
In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice. J Appl Bacteriol (1985) 0.87
Effect of sulphasalazine on the human intestinal flora. J Appl Bacteriol (1982) 0.86
[Influence of the zoological species on the microflora of the gastrointestinal tract]. Rev Immunol Ther Antimicrob (1970) 0.84
Selective decontamination of the digestive tract by pipemidic acid. Antimicrob Agents Chemother (1983) 0.84
COLISTIN SUPPRESSION OF ESCHERICHIA COLI IN STOOLS. II. REDUCTION OF FECAL EXCRETION OF NON-ENTEROPATHOGENIC ESCHERICHIA COLI IN INFANTS WITH DIARRHEA. Am J Dis Child (1964) 0.80
Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta (1992) 5.09
Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 3.21
Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother (1987) 2.80
Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis (2001) 2.48
Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol (1999) 2.12
Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol (1988) 2.00
Effect of erythromycin on microbial antagonisms: a study in gnotobiotic mice associated with a human fecal flora. J Infect Dis (1983) 1.90
Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet (1999) 1.83
Plasmid-mediated high-level resistance to erythromycin in Escherichia coli. Antimicrob Agents Chemother (1986) 1.72
Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother (1991) 1.68
Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol (1990) 1.56
Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis (1991) 1.51
Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin. Ann Microbiol (Paris) (1982) 1.48
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents (2000) 1.48
Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients. Infect Immun (2000) 1.47
Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol (1998) 1.42
Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect (2002) 1.42
Comparison of ribotyping, pulsed-field gel electrophoresis and random amplified polymorphic DNA for typing Clostridium difficile strains. FEMS Microbiol Lett (1994) 1.40
Random amplified polymorphic DNA typing versus pulsed-field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci. J Clin Microbiol (1996) 1.35
Decontamination of polymerase chain reaction reagents for detection of low concentrations of 16S rRNA genes. Mol Biotechnol (1997) 1.34
Epidemiology of intestinal colonization by members of the family Enterobacteriaceae highly resistant to erythromycin in a hematology-oncology unit. Antimicrob Agents Chemother (1986) 1.30
Detection of genes in feces by booster polymerase chain reaction. J Clin Microbiol (1992) 1.20
Plasmid-mediated susceptibility to intestinal microbial antagonisms in Escherichia coli. Infect Immun (1985) 1.19
Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients. J Clin Microbiol (1987) 1.14
Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. J Hosp Infect (2007) 1.11
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis (1994) 1.11
Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun (2001) 1.11
Epidemiology of bacterial infection during management of open leg fractures. Eur J Clin Microbiol Infect Dis (1999) 1.08
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles. Antimicrob Agents Chemother (1989) 1.08
Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrob Agents Chemother (1987) 1.07
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol (1990) 1.07
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst (1996) 1.06
Characterization of AfaE adhesins produced by extraintestinal and intestinal human Escherichia coli isolates: PCR assays for detection of Afa adhesins that do or do not recognize Dr blood group antigens. J Clin Microbiol (2001) 1.06
Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain. Euro Surveill (2010) 1.01
Conjugal transfer of plasmid DNA from Enterococcus faecalis to Escherichia coli in digestive tracts of gnotobiotic mice. Antimicrob Agents Chemother (1992) 1.01
Trichoderma pseudokoningii as a cause of fatal infection in a bone marrow transplant recipient. Clin Infect Dis (1995) 1.00
Use of beta-lactamase-producing anaerobes to prevent ceftriaxone from degrading intestinal resistance to colonization. J Infect Dis (1989) 0.99
Comparative translocation of enteropathogenic Campylobacter spp. and Escherichia coli from the intestinal tract of gnotobiotic mice. Infect Immun (1987) 0.99
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematol J (2000) 0.97
Effectiveness of nanoparticle-bound ampicillin in the treatment of Listeria monocytogenes infection in athymic nude mice. Antimicrob Agents Chemother (1988) 0.97
Heterogeneity of genes conferring high-level resistance to erythromycin by inactivation in enterobacteria. Ann Inst Pasteur Microbiol (1988) 0.95
Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm Res (1991) 0.95
Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med (2000) 0.94
Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit. Antimicrob Agents Chemother (1986) 0.93
Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. J Antimicrob Chemother (1990) 0.92
Hand contamination before and after different hand hygiene techniques: a randomized clinical trial. J Hosp Infect (2002) 0.91
Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo. Antimicrob Agents Chemother (1992) 0.91
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis (2011) 0.91
Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice. Antimicrob Agents Chemother (1991) 0.90
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill (2014) 0.88
Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J Control Release (1998) 0.88
Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Int J Pharm (1999) 0.88
In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice. J Appl Bacteriol (1985) 0.87
Streptococcal septicaemia following autologous bone marrow transplantation in children treated with high-dose chemotherapy. Bone Marrow Transplant (1991) 0.87
Shedding of antibiotic-resistant members of the family Enterobacteriaceae in healthy residents of France and Jordan. Res Microbiol (1995) 0.87
Single-step polymerase chain reaction for combined gene detection and epidemiological typing in three bacterial models. FEMS Microbiol Lett (1997) 0.87
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med (1993) 0.87
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clin Microbiol Infect (2003) 0.86
Production of haemolysin, aerobactin and enterobactin by strains of Escherichia coli causing bacteraemia in cancer patients, and their resistance to human serum. Res Microbiol (1989) 0.86
Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice. Appl Environ Microbiol (1991) 0.86
Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. J Microencapsul (1991) 0.86
Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647). Antimicrob Agents Chemother (2001) 0.86
[Comparison between the number and nature of fecal clostridia and other risk factors implicated in the intestinal pathology of newborn infants]. Ann Inst Pasteur Microbiol (1988) 0.85
Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. J Microencapsul (1998) 0.85
Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother (1989) 0.85
Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design. Eur J Clin Microbiol Infect Dis (2012) 0.85
Impact of quinupristin/dalfopristin (RP59500) on the faecal microflora in healthy volunteers. J Antimicrob Chemother (2002) 0.84
A polysorbate-based non-ionic surfactant can modulate loading and release of beta-lactoglobulin entrapped in multiphase poly(DL-lactide-co-glycolide) microspheres. Pharm Res (1999) 0.83
Activity and specificity of a mouse monoclonal antibody to ferric aerobactin. Infect Immun (1992) 0.83
Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis. Antimicrob Agents Chemother (1991) 0.83
Influence of colonizing micro-flora on the mucin histochemistry of the neonatal mouse colon. Histochem J (1990) 0.82
Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopy. Infection (1991) 0.82
Induction of systemic immunologic tolerance to beta-lactoglobulin by oral administration of a whey protein hydrolysate. J Allergy Clin Immunol (1997) 0.82
[Effect of erythromycin on the populations of enterobacteria in the human digestive tract]. Nouv Presse Med (1980) 0.81
Interactions between Helicobacter pylori and the local mucosal immune system. Scand J Gastroenterol Suppl (1991) 0.81
Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres. Infect Immun (1997) 0.81
Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country. Clin Microbiol Infect (2014) 0.81
Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with streptococcus pneumoniae. Vaccine (2000) 0.81
Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation? Br J Haematol (1997) 0.81
Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles. J Antimicrob Chemother (1996) 0.81
Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres. Vaccine (1998) 0.80
Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime. Antimicrob Agents Chemother (1993) 0.80
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients. Eur J Cancer (1992) 0.80
Immunological variants of the aerobactin-cloacin DF13 outer membrane protein receptor IutA among enteric bacteria. Infect Immun (1994) 0.79
Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever: a possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy-coagulopathy. Arthritis Rheum (1999) 0.79
Comparison of chemical assay, bioassay, enzyme-linked immunosorbent assay, and dot blot hybridization for detection of aerobactin in members of the family Enterobacteriaceae. Appl Environ Microbiol (1993) 0.78
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients. J Antimicrob Chemother (1998) 0.78